1 / 39

Making Science Work For You

. Contents. Jubilant Current ProfilePharmaceuticals

russ
Download Presentation

Making Science Work For You

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    2. Contents

    3. Jubilant Profile

    6. Contents

    13. Contents

    14. Research & Development

    15. Technology Platforms – Jubilant Strength

    16. Contents

    20. Advance Intermediates – Product Offerings

    21. Nutritional products – Product Offerings

    22. NIACIN & NIACINAMIDE

    24. Contents

    26. Contents Jubilant Profile Jubilant Business Dimension Jubilant Locations Research & Development Pharmaceuticals & Life Science business Products & Services Advance Intermediates & Vitamins Business Model Business Excellence Quality and Compliance Corporate Governance and Sustainability Business Advantage with Jubilant

    27. Quality & Compliance - Corporate GMP Corporate Quality Plan Integration of Quality Systems at all Manufacturing and R&D Facilities GMP & GLP Training Unified Corporate QA Guideline for Harmonozation Guidelines on key GMP systems issued for implementation Corporate QA Audits at all Facilities Audit Compliance and CAPA Vendor Audit Program Periodic Quality Reviews Customer Regulatory Audits Our site is audited by top twenty US and EU pharmaceuticals companies without inviting any major non- conformances Our API plant was approved by US-FDA in year 2001, 2004 and re-approved in 2008 All manufacturing sites has got accreditation of ISO 9001 : 200, ISO 14001 & ISO 18001 All our international plants for both sterile( liquid and lyophilized) & non sterile (liquid, cream tablets and capsules) are approved by multiple regulatory authorities like US FDA, EU EMEA, Japan PMDA etc More than 330 no. of people in Quality and 40 no. of people in regulatory across the organization

    28. All identified Products have already been pre-registered under REACH regulations with ECHA (European Chemical Agency). Hence our business is REACH compliant from 1 Jan, 2009. Process of inquiring feedback on final registration from the EU customers initiated We will prefer to use the registration of EU customers. Deadline for final registration of our products (100+TPA) is May 2013. Our Only Representative- Mr Koen Laenen, Jubilant Pharmaceuticals NV, Belgium REACH compliance statement is uploaded in Jubilant website with help desk details-reach@jubl.com REACH

    29. Contents Jubilant Profile Jubilant Business Dimension Jubilant Locations Research & Development Pharmaceuticals & Life Science business Products & Services Advance Intermediates & Vitamins Business Model Business Excellence Quality and Compliance Corporate Governance and Sustainability Business Advantage with Jubilant

    30. Information System and Corporate Governance Jubilant has integrated information system which provides complete visibility and speed to our all key business Jubilant is also in the process of integrating and standardizing all the various information system by newly acquired by newly acquired subsidiaries and integrating into one information system Risk control mapping and remediation plans for each of the business and for the company as a whole Documentation as per Sarbanes Oxley Act of USA Voluntary disclosure of US GAAP and IFRS Accounts Complete transparent investor relation policy and communication with all the key stake-holders

    31. Corporate Sustainability Company is conscious of the fact that while we strive of the economic growth, we have a large responsibility to protect environment, health and safety of operations and be responsible to the society In the area of environment, the company believes in protecting the environment while continuing to do business. The focus areas of the company are to reduce fresh water consumption and improving on energy consumption norms The company gives specific thrust in conserving energy usage and has taken up several initiatives for energy conservation Jubilant has achieved international safety standards through quarterly assessments and continuous reviews and action plans for improvements Jubilant has partnered through its own initiative and public private partnership with WHO, UNDP and many other NGOs have implemented many important social programs in and around our facilities in the area of educations and health including TB and HIV detection, treatment and eradication Jubilant publishes Corporate Sustainability Report every year audited by Ernst & Young as per Global Initiative ( GRI) covering detailed account of company's activities in the area of economics, environmental and social ( Triple bottom line) Jubilant is the only pharma company worldwide who has received A+ rating from GRI for its Corporate Sustainability report

    32. Recognition for Sustainability efforts 2008 – Global Golden Peacock award for CSR 2008-Featured in the Top 10 company of India in Standard and Poor’s in Environment, social and Governance (ESG) index 2007 : Featured in the IFC document as one of the four company who have successfully integrated sustainability in business 2007 : Invited to International meet in Moscow for presenting the only case study from India on Public Private Partnership (PPP) model (DOTs Centre for TB treatment at Gajraula) 2007 : Jubilant Sustainability Report 2007 short listed for Reader’s Choice award from 800 reports Globally 2007 : Certificate of commendation from CII for its Sustainability performance 2007 : Finalist at the Bombay Stock Exchange award for CSR 2007 : Finalist at the National Golden Peacock award for CSR

    33. Other Awards and Recognitions Received National Energy Conservation Award from Government of India in five out of last six years 2004 : Figured in Forbes 100 list of companies under $ 1billion in the Asia Pacific & European regions 2004 : Sir Archarya P C Ray Award for Development of Indigenous Technology 2004 : Best implemented 6 sigma initiatives by CII 2004 : Golden Peacock Award for innovation management from Institute of Directors 2005 : Golden Peacock Award for Corporate Social Responsibility 2006 : Finalist in Golden Peacock Award for Institute of Company 2006 Selected as one of the top 25 companies for Institute of Company Secretaries of India National Award for Excellence in Corporate Governance 2007 : Golden Peacock Global Award for Excellence in Corporate Governance – 2007

    34. Contents Jubilant Profile Jubilant Business Dimension Jubilant Locations Research & Development Pharmaceuticals & Life Science business Products & Services Advance Intermediates & Vitamins Business Model Business Excellence Quality and Compliance Corporate Governance and Sustainability Business Advantage with Jubilant

    36. Thank You

More Related